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Summary
Pseudomonas aeruginosa is an opportunistic human
pathogen that forms highly stable communities –
biofilms, which contribute to the establishment and
maintenance of infections. The biofilm state and
intrinsic/acquired bacterial resistance mechanisms
contribute to resistance/tolerance to antibiotics that is
frequently observed in P. aeruginosa isolates. Here we
describe the isolation and characterization of six novel
lytic bacteriophages: viruses that infect bacteria,
which together efficiently infect and kill a wide range of
P. aeruginosa clinical isolates. The phages were used
to formulate a cocktail with the potential to eliminate
P. aeruginosa PAO1 planktonic cultures. Two biofilm
models were studied, one static and one dynamic, and
the phage cocktail was assessed for its ability to
reduce and disperse the biofilm biomass. For the static
model, after 4 h of contact with the phage suspension
(MOI 10) more than 95% of biofilm biomass was elimi-
nated. In the flow biofilm model, a slower rate of activ-
ity by the phage was observed, but 48 h after addition
of the phage cocktail the biofilm was dispersed, with
most cells eliminated (> 4 logs) comparing with the
control. This cocktail has the potential for develop-
ment as a therapeutic to control P. aeruginosa infec-
tions, which are predominantly biofilm centred.
Introduction
Pseudomonas aeruginosa are waterborne, highly versa-
tile bacteria with minimal growth requirements that are
ubiquitous in the environment (Frimmersdorf et al., 2010).
Although, not part of the normal human flora, their versa-
tility allows them to become serious and occasionally fatal
pathogenic agents, if the opportunity for infection and
growth is presented. The bacteria are often found colo-
nizing hospital settings and medical devices, such
as indwelling catheters (Gilsdorf et al., 1989).
Immunocompromised patients are commonly colonized,
and this can lead to chronic pulmonary infections in cystic
fibrosis (CF) patients, and skin and soft tissue infections
of severe burn victims that can ultimately lead to bacte-
raemia. Apart from their versatility, two additional factors
make these bacteria directly on the top of the most prob-
lematic and challenging bacterial pathogens to treat.
Pseudomonas aeruginosa cells commonly form biofilm
communities, especially when infecting wounds or the
lungs; here the infection establishes more effectively and
resilience to environmental stresses is higher (Drenkard,
2003). Second, the incidence of P. aeruginosa antibiotic-
resistant isolates has increased significantly over the past
two decades (Lister et al., 2009) and the species has
acquired resistance to every licensed antibiotic class
(Strateva and Yordanov, 2009). Inappropriate antibiotic
use has selected for resistance in a species with a high
recombination rate and exceptional genomic diversity
(Kos et al., 2015). In addition, defects in the P. aeruginosa
methyl-directed mismatch repair (MMR) system make
mutation recognition and repair less effective, leading to
hypermutability. In fact, it was reported in a study in CF
patients suffering from a chronic P. aeruginosa infection
that 36% of the isolates showed a hypermutability pheno-
type (Oliver et al., 2000). For this reason, alternatives to
antimicrobial drugs are being investigated to treat biofilm
infections caused by antibiotic-resistant P. aeruginosa iso-
lates. Bacteriophages (phages) are a possible alternative
to antibiotic drugs, with several potential advantages.
Phages are natural predators of bacteria and phage infec-
tion and killing of bacteria has a completely different mode
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of action to antibiotics. Consequently, antibiotic-resistant
bacteria present no special challenge to phage therapy
(Mann, 2008; Kutter et al., 2010). Phages are versatile
agents that can be used in liquid, impregnated into
hydrogels or solids, and are hence suitable not only for
use by most delivery routes, such as topical application
and inhalation, but also oral and parental delivery
(Matsuzaki et al., 2005; Bean et al., 2014; Esteban
et al., 2014). An additional advantage of phage already
with promising results (Fu et al., 2010; Pires et al., 2011;
Alves et al., 2014) is their ability to disrupt and eradicate
biofilms (for review see Harper et al., 2014): (i) phage
amplification allows access to the cells buried deeper
in the biofilm; (ii) phages can carry or express
depolymerizing enzymes that degrade the inter-cellular
polysaccharide matrix present in biofilm; (iii) if not coding
for a depolymerase enzyme, the phages can induce
expression of depolymerases from within the host
genome (Bartell and Orr, 1969); (iv) ‘persister’ cells can
still be infected by phages, although no proliferation will
occur until these cells are ‘awakened’, after which phage
replication will take place and burst the cell (Pearl et al.,
2008). Here we describe not only the isolation and char-
acterization of six novel phages against clinical strains of
P. aeruginosa, but also we assess their antimicrobial effi-
cacy in planktonic and in static and flow biofilm models.
Results
Phage cocktail isolation and host range determination
Phages were isolated from sewage and flood water
samples after enrichment with P. aeruginosa strains of
diverse clinical isolates, obtained from both acute and
chronic clinical situations, listed in Table 1. Six phages
showing clear isolated plaques surrounded by halos were
selected. Halos are caused by the diffusion of enzymatic
molecules and are usually an indication of a phage
capable of displaying enzymatic activity towards the
polysaccharide matrix of biofilms (Hughes et al., 1998).
Lytic phages were evaluated with respect to their
host range of infectivity. Phages were tested against
P. aeruginosa isolates in order to select those with broad
host ranges. Six of the 11 phages tested were selected to
establish a phage cocktail, as their combination gave the
highest percentage of coverage against the target patho-
gens (Table 2). Hence, the selected phages – DL52,
DL54, DL60, DL62, DL64 and DL68 – gave a total cover-
age of 90% [95% confidence interval (CI), 62% to 94%; 18
isolates out of 22 were susceptible].
Morphology of phage particles
The six P. aeruginosa phages were characterized with
respect to their morphology under transmission electron
microscopy. Two different types of morphology were
identified, as shown in Fig. 1. DL52, DL60 and DL68
phages posse an icosahedral head of ∼ 60 nm, ∼ 76 nm
and ∼ 72 nm in diameter respectively. Long contractile
tails, with tail fibres, of approximately ∼ 123 × 18 nm,
∼ 95 × 19 nm and ∼ 177 × 23 nm, respectively, were also
observed. Phages DL54, DL62 and DL64 have an
icosahedral head of approximately ∼ 45 nm, ∼ 63 nm and
∼ 65 nm in diameter, respectively, and a short tail of
∼ 12 × 9 nm and ∼ 13 × 9 nm with no tail fibres being
Table 1. List of human bacterial P. aeruginosa strains isolated from acute and chronic sites of infection, with their respective country of origin and
related information.
Isolate ST Country Source
PAO1 – Standard Laboratory Reference Strain (250)
Acute infections PA45311 – Bristol, UK n.d.
PA45291 – Bristol, UK n.d.
PA45235 – Bristol, UK n.d.
PA45379 – Bristol, UK n.d.
PA45321 – Bristol, UK n.d.
Chronic
infections
BC00918 – Genova , Italy CF, Male, 23
BC01026 – Australia n.d.
BC00909 – Paris, France CF, Male, 25
BC00888 1517 Utrecht, The Netherlands CF, M, 11/01/2007
BC00907 1528 Paris, France CF, Female, 24
BC00917 1544 Genova , Italy CF, Male, 29 years
BC00920 1547 Lisbon, Portugal CF, Male, 32 years
BC00921 1535 Lisbon, Portugal CF, Female, 37 Years
BC00922 155 Lisbon, Portugal CF, Female, 8 Years
BC00923 1548 Lisbon, Portugal CF, Female, 19 years
BC00931 – Bordeaux, France CF, Female
BC00932 1529 Bordeaux, France CF, Male
BC00933 1530 Bordeaux, France CF, Female
BC00934 1552 Bordeaux, France CF, Male
BC00935 – Bordeaux, France CF, Male
CF, cystic fibrosis; n.d., no data available.
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visible. For DL64 the tail was clearly visible; however,
fibres protruding from the capsid are observed. According
to the system of Ackermann classification (Ackermann,
2006) such morphology shows the first group of phages
as belonging to the Myoviridae family and the second
group as belonging to the Podoviridae family, both from
the order Caudovirales. The samples of the observed
Myoviridae phages showed the presence of many disin-
tegrated phages, where several free capsids and free tails
could be observed. Samples of phages DL54 and DL60
showed the presence of phage aggregates.
Phage genomic characterization
DNA from six P. aeruginosa phages was extracted and
genome sequencing was performed. All six phages seem
to have a linear dsDNA genome with terminal redundancy,
suggesting that they have a headful packaging system
(Streisinger et al., 1967). The genome sizes observed for
phages DL52, DL60 and DL68 comprised 65 867 bp,
66 103 bp and 66 111 bp respectively. Figure 2 shows a
comparison between these Myoviridae phages, per-
formed using the BLASTN algorithm (Madden, 2003). The
phages share 90% of their nucleotide sequence and in
particular DL52 and DL60 are 96% identical. Genes are
arranged in a typically compact manner with a coding
percentage ranging from 89.7% to 91.6% and tRNA
genes are absent from all of the phages. Ps aeruginosa
shows a G + C% content of 66.6% and for all phages their
G + C% content was lower (between 52.4% and 62.2%).
Phages DL52 and DL60 show strong genomic similarities
to phage PB1 (> 96%) and phage LBL3 (> 92%), which
have recently been sequenced (Ceyssens et al., 2009).
Phage DL68 shares high similarities with phage KPP12
DNA (96%) (Fukuda et al., 2012), but is still strongly
related to PB1 and LBL3 phages (> 90%). In accordance
with other related phages such as PB1 (Ceyssens et al.,
2009), RNA polymerases are absent in all three phages,
which is commonly observed for these types of phages,
where transcription relies entirely on the host machinery.
All three phages carry a DNA polymerase III alpha-subunit
that catalyses the polymerization reaction of the host DNA
polymerase III holoenzyme, which is the DNA polymerase
observed within bacteria (Kelman and O’Donnell, 1995).
The presence of phage-encoded DNA primase and
helicase suggests that viral dsDNA elongation is per-
formed by the phage independently of the host replication
machinery. For the three phages the majority of genes are
found in the positive strand (57.8%, 59.6% and 57.6%, for
DL52, DL60 and DL68 respectively), whereas the others
are found in the negative strand (42.2%, 40.4% and
42.4%, for DL52, DL60 and DL68 respectively).
The genome size observed for the Podoviridae phages
DL54 and DL62 was similar, comprising 45 673 bp and
42 508 bp respectively. Phage DL64 genome was much
larger comprising 72 378 bp (Fig. 3). A comparison
between the nucleotide sequence of DL54, DL62 and
DL64 showed no shared similarities. DL54 shares strong
similarities (> 98%) with other lytic Podoviridae infecting
P. aeruginosa, such as phiIBB-PAA2 and LUZ24
(Ceyssens et al., 2008; Pires et al., 2014). Phage LUZ24
has two tRNA genes present in its genome; however, for
DL54 tRNA was not observed in the genome sequence
(Ceyssens et al., 2008). It is possible to recognize a con-
served coding region responsible for phage assembly
(large subunit of the terminase and upstream of the portal,
capsid and scaffolding protein genes) and a region for
DNA metabolism similarly, where the DNA polymerase
was fragmented into three parts by an endonuclease
gene, as observed for phage LUZ24 (Ceyssens et al.,
2008). The DNA primase/helicase gene can also be found
in the middle of the DNA polymerase. The two main
modules are separated by several potential coding genes
for phage proteins with unknown roles. The majority of
genes, 50 (70.4%), are found in the positive strand, and
21 (29.6%) are found in the negative strand. The search
using the BLASTN algorithm in the NCBI database showed
that phage DL62 is closely related to phiKMV-like phages
(> 95%), such as phiKMV and LUZ19 (Lavigne et al.,
2003; Lammens et al., 2009) and these phages are
grouped into the T7-like phage genus in the subfamily of
Table 2. Sensitivity screening of phage cocktail against P.
aeruginosa clinical isolates.
Pseudomonas
aeruginosa
isolates D
L5
2
D
L5
4
D
L6
0
D
L6
2
D
L6
4
D
L6
8
Co
ck
ta
il
BC00932 I I I S I S S
BC00931 I R I I I S S
BC00923 R I I R R R I
PAO1 S S S S S S S
BCO1O26 I I R S S S S
BC00935 S S S I S S S
BC00934 R S S I I S S
PAB45379 I I R S R I S
BC00907 S S S S S S S
PAB45235 R R R I S I S
PAB45321 R R I R R R I
PAB45291 S S S S S S S
BCOO909 R R R S R I S
BC00918 R R R S R R S
BC00917 R I R I S S S
BC00920 S S S I S S S
BC00921 R R I R R R I
PAB45311 I R R R R R I
BC00922 I I R S S I S
BC00888 I I R R S S S
BC00933 S S I R S S S
BC00920 I R I S S S S
Hit % 30 35 30 50 60 65 90
Bacterial isolates were susceptible (clear spot; S; green),
intermediate (turbid spot; I; yellow), or resistant (no disturbance of
bacterial lawn; R; red) to phage infection.
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the Autographivirinae. Genomes of T7-type phage have
been previously sequenced for phages of Klebsiella pneu-
monia, for example (Drulis-Kawa et al., 2011), where
genes are arranged into three clusters: early genes
(cluster I), DNA metabolism (class II) and structural pro-
teins for phage assembly and for host lysis (class III)
(Lavigne et al., 2003). Such genome organization is
clearly observed for phage DL62. However, differences
Fig. 1. Electron micrograph images of phage (A) DL52, (B) DL54, (C) DL60, (D) DL62, (E) DL64 and (F) DL68 infecting P. aeruginosa nega-
tively stained with 1% uranyl acetate. Scale is indicated by the bars.
Fig. 2. Comparative genomic analysis of the annotated Myoviridae phages DL52, DL60 and DL68. Nucleotide sequences were compared
using the Artemis Comparison Tool (ACT). Predicted reading frames are denoted by arrows and genes encoding proteins with at least 73%
amino acid identity between the genomes are indicated by shaded regions.
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can be found, such as the RNA polymerase that in T7-like
phages is present in cluster I of early genes and both in
DL62 and phiKMV phages is present within the class II
cluster. Typically the genome has a gene pairing lysin–
holin in order to breakdown the bacterial cell. Phage DL62
carries a lysin (ORF51) found within cluster III, possibly
with muraminidase activity, and the position and small
size (66 residues) of ORF52 might code for the holin
(Young and Bläsi, 1995; Wang et al., 2000). Like phiKMV
(Lavigne et al., 2003), phage DL62 has a higher G + C%
content (62.2%) when in comparison with the other
phages of the cocktail, being close to the G + C% content
of the bacterial host (65%) (Stover et al., 2000) and in
accordance with the homologue phiKMV phage (Lavigne
et al., 2003). Genes were all found in the forward strand,
but the first gene is located in the reverse strand. Lastly,
phage DL64 showed a unique genome sequence. The
most striking feature of the genome is the presence of two
genes (ORF41 and ORF42) homologous to rIIA-like and
rIIB-like proteins from phage N4 that, although not yet
clear, might play a role in the phenomenon of lysis inhibi-
tion and in other functions, such as interference in cell
metabolism (Paddison et al., 1998). Lysis inhibition is
defined as a delay of the phage in producing the enzyme
holin while phage particles are being produced, resulting
in their accumulation inside the host. Phage DL64
genome can be grouped in the N4-like phages, such as
LIT1 (98% nucleotide identity) and LUZ7 (73% nucleotide
identity) that have been previously sequenced (Ceyssens
et al., 2010) and several others on which genome descrip-
tion can be found in GenBank. N4-like phages use three
distinct RNA polymerases during their lytic infection cycle:
a giant virion-encapsulated RNA polymerase that is
co-injected with the phage genome into the host upon
infection, a heterodimeric phage RNA polymerase tran-
scribed from the middle region and a DNA-binding protein
that is able to arrest the host RNA polymerase to tran-
scribe late phage proteins (Miller et al., 1997). Although,
the BLAST search only predicted one RNA polymerase, we
can presume that ORF15 might code for the giant RNA
polymerase, as it is positioned in the early gene regions
and its large size (3398 residues). It is suggested that the
DNA-binding protein coding gene might be ORF66 posi-
tioned directly upstream of the predicted RNA polymerase
1 (ORF67) with 88 residues. N4 phage codes for three
tRNAs; however, no tRNAs were predicted for phage
DL64 and phages LUZ7 and LIT1 (Ceyssens et al., 2010).
No potential coding gene was predicted not only for the
lytic enzyme for DL64, but also for LUZ7 and LIT1, and it
is suggested that these phages might code for a novel
type of endolysin or execute a different lysis mechanism
(Ceyssens et al., 2010). A DNA polymerase I, a DNA
helicase and primase are included in the genome of
phage DL64, suggesting a host independency for DNA
replication. The genome organization seems to be divided
into two large clusters positioned on different strands and
in their middle two small clusters are present, which are
transcribed from opposite directions. This can also be
observed for phages LUZ7 and LIT1 (Ceyssens et al.,
2010). Hence, the first larger cluster includes transcrip-
tion, DNA replication and lysis inhibition, a first small
cluster that comprises a DNA primase, a second small
cluster for structural proteins followed by the second large
cluster for DNA package. The great majority of the genes,
70 (77.8%), are found in the leftward strand, and the other
20 genes (22.2%) in the opposite strand. The gene-coding
potential of these phages ranges from 1.243 to 1.391
genes per kilobase. Phage DL54 stands out from the
Fig. 3. Representation of the annotated Podoviridae phages DL54, DLA62 and DL64. Nucleotide sequences were analysed using the Artemis
tool and predicted reading frames are denoted by arrows.
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other phages exhibiting the highest gene density of 1.554
genes per kilobase. Although for the great majority of
potential coding regions (more than 60% for all cases) no
known function has yet been found. The six DNA
sequences were searched for the presence of antimicro-
bial genes and for any known virulence factor. Results
from this search revealed that all six phages do not carry
any potential genes coding for known antibiotic resistance
or virulence factors and lysogeny modules were not found
to be present. Table 3 summarizes the key features of the
six genomes (see also Tables S1–S6 for general features
of putative ORFs in the Supporting information).
Bacteriophage mixture inhibits planktonic bacterial growth
The efficacy of each of the six individual phages and their
combination into a cocktail was assessed by inoculating a
bacterial broth culture of P. aeruginosa PAO1. Suspen-
sions containing the phages were prepared to achieve a
Multiplicity of Infectivity (MOI, the ratio of virus particles to
viable bacterial cells) of 0.1 in the culture and this was
introduced after 2 h of incubation of the latter. Growth
continued for a further 22 h period. Figure 4 shows that for
all individual phage suspensions there was eventually a
regrowth of the PAO1 culture between 8 and 13 h after
phage inoculation (time points: 10–15 h). Conversely, by
using a suspension of the six phages in a cocktail, no
regrowth and a full inhibition of the bacterial culture were
observed.
Bacteriophage mixture eradicates biofilms under
static conditions
In order to assess the potential of the phage cocktail to
eradicate biofilms under static conditions, 48 h biofilms
produced by P. aeruginosa PAO1 were established in
Table 3. Summary of general genome features of the phage cocktail.
Phage
Taxonomic
family
Genome
size
Number of
predicted ORFs G + C%
Gene density
(genes per kilobase) Coding%
DL52 Myoviridae 65 867 90 54.9 1.366 89.7
DL54 Podoviridae 45 673 71 52.4 1.554 92.4
DL60 Myoviridae 66 103 89 54.9 1.346 89.8
DL62 Podoviridae 42 508 55 62.2 1.293 94.4
DL64 Podoviridae 72 378 90 55.0 1.243 92.5
DL68 Myoviridae 66 111 92 55.7 1.391 91.6
Fig. 4. Dynamic of P. aeruginosa PAO1 bacteria with single phage and phage cocktail in liquid cultures over 24 h of incubation at 37°C. Absorb-
ance readings at 600 nm were taken in a microtitre plate reader. Pseudomonas aeruginosa PAO1 isolate growing with only SM buffer ( ), with
single DL52 ( ), DL54 ( ), DL60 ( ), DL62 ( ), DL64 ( ) DL68 ( ) and with the phage cocktail in SM buffer ( ) and also a negative-control
SM-only buffer ( ) are shown in the figure. Assays were performed three times, and OD600 was expressed as the mean ± standard deviation.
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96-well polystyrene microtitre plates. Washing steps were
performed carefully as the mechanical wash step could
disrupt the very viscous biofilms because of their high
polysaccharides content. Established biofilms were
treated with the phage cocktail at two different MOIs, 1
and 10, and their biomass density was assessed at 0, 2,
4, 24 and 48 h, by crystal violet staining followed by OD600
measurements (Fig. 5A). An 80% reduction of the biofilm
biomass was observed in the first 4 h of phage treatment
for MOI 1, and more than 95% reduction was observed for
MOI 10 (P < 0.05) when compared with the PBS control.
At 24 h, although biofilm biomass was still lower than for
the PBS controls biofilm wells for both MOI cases (MOI of
10, P = 0.015; MOI of 1, P = 0.003) (Figs 5A and S7),
there was biofilm regrowth compared with 4 h after phage
addition. By the end of the experiment at 48 h, the biofilm
biomass measured was greater than the biomass of the
control biofilms. In parallel, an tetrazolium dye (XTT)
assay was performed to evaluate the metabolic activity of
the cells in the biofilm when treated with a phage cocktail
suspension at MOI 10 over 48 h. In comparison with the
PBS control a decrease in metabolic activity during the
first 4 h of treatment (P < 0.05) was observed (Figs 5C
and S7), and this was followed by a regrowth. Although in
this case, by 48 h the regrown biofilm did not surpass the
biomass of the biofilms inoculated only with PBS, showing
lower numbers (P < 0.05). In a similar experiment,
biofilms were disrupted and both bacterial and phages
number were estimated. The same behaviour was
observed, where in the first 4 h of treatment there was a
clear reduction of the viable cell number, followed by a
regrowth measured at 24 h. By 48 h a ∼ 1 log cell number
reduction was observed; however, this was also seen with
the disrupted control biofilm (Fig. 5B). Regarding the
phage numbers in the biofilm, it was seen that at 4 h there
was a decrease in phage concentration, most likely due to
Fig. 5. Pseudomonas aeruginosa PAO1 biofilm treated with the phage cocktail over 48 h. (A) Normalized biofilm biomass treated with the
phage cocktail at two different MOIs (OD600 reading after CV staining). (C) Normalized cell metabolic activity in the biofilm treated with the
phage cocktail at MOI 1 (OD600 reading after XTT assay). (B) and (D) show the estimation of numbers of viable bacterial cells and phage parti-
cles in the biofilms treated with the phage cocktail. Assays were performed three times, and the means ± standard deviations are indicated.
Statistical significance of biofilm reduction was assessed by performing Student’s t-test. P-values are indicated (*P < 0.05).
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many of the phages still infecting the cells and not being
present in the surrounding environment. At 24 and 48 h,
the number of phages present in the biofilm increased by
∼ 2 logs (Fig. 5D). For all cases a higher MOI was found to
be more effective in rapidly reducing the biofilm biomass
and also better at preventing the consequent biofilm
regrowth.
Bacteriophage mixture eradicates biofilms under
dynamic conditions
In order to mimic a more realistic infection situation a
continuous growing culture of P. aeruginosa PAO1 was
established to allow the production of a 48 h biofilm under
dynamic flowing conditions. The biofilm was then treated
with an emulsion suspension of the phage cocktail at an
MOI of 0.1 and the biofilm was assessed for eradication
and dispersion. Results showed a clear reduction of the
biofilm and by 24 h of phage treatment this reduction was
significantly different from the PBS-treated biofilm control
(Fig. 6A, P = 0.003) and by 48 h such reduction was even
more evident (P = 0.00008). Via confocal microscopy,
biofilms produced on the modified Robbins device (MRD)
flow system were shown to have structures composed of
a majority of live cells, although dead cells and possibly
water channels could also be observed. Biofilm reduction
and dispersion was also seen (Fig. 6C), and by 48 h the
presence of a biofilm on the stainless steel discs was
barely visible with only a few dispersed bacterial aggre-
gates. These results are reinforced by an increase in the
number of phages present in the disrupted biofilms of
∼ 3 logs (Fig. 6B). Also, the initial concentration of phage
particles recovered from the disrupted biofilms was lower
than the amount injected – indicating either washout of
phage, or more likely lack of opportunity for infection and
reproduction due to loss of biofilm.
Discussion
In this study six phages were isolated from environmental
sources and combined in a cocktail suspension that
proved to be strongly lytic against a wide range of
P. aeruginosa diverse clinical isolates, showing host cov-
erage of 90% of the isolates collection tested. Based on
transmission electron microscope (TEM) and genome
sequencing, phages DL52, DL60 and DL68 belong to the
Myoviridae long-contractile tailed phage family and DL54,
DL62 and DL64 belong to the Podoviridae short-tailed
Fig. 6. Pseudomonas aeruginosa PAO1 48 h biofilm grown under flow conditions in the Robbins device and treated with a phage in emulsion
suspension or PBS in emulsion suspension (control) for 48 h. (A) Number of viable cells recovered from the disruption of the biofilms; (B)
number of phage particles recovered from the disputed biofilms; (C) 3D images of the biofilms observed under the confocal microscope
stained with LIVE/DEAD stain at a magnification of 20×. Live (green) and dead (red) bacterial cells can be observed on the surface of the
stainless steel disc. Enumeration assays were performed three times, and the means ± standard deviations are indicated. Statistical signifi-
cance of biofilm reduction was assessed by performing Student’s t-test. P-values are indicated (*P < 0.05; ***P < 0.001).
68 D. R. Alves et al.
ª 2015 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology, Microbial
Biotechnology, 9, 61–74
phages family. Phage aggregation could be observed for
phages 54 and 60, this behaviour is observed in nature
(Hejkal et al., 1981; Narang and Codd, 1981) and has
been attributed to pH, composition of ions and ionic
strength. At the genome level all phages were revealed to
be double-stranded DNA (dsDNA), with high gene density
and low G + C% compared with the host P. aeruginosa
PAO1. The three Myoviridae phages were shown to be
strongly related and they can be placed in the PB1-like
lytic virus group. It has been documented that these
phages use the bacterial lipopolysaccharide as a receptor
to attach to the cell (Jarrell and Kropinski, 1977) and we
can assume that the same attachment mechanism might
be employed by these three phages. Regarding the
Podoviridae phages no interrelatedness was observed.
Phage DL64 have a large genome compared with the
other two, and DL54 showed the highest gene density.
Interestingly, phage DL64 appears to carry the rIIA/rIIB
lysis inhibition cassette, which is widely distributed among
the genomes of phages infecting different host genera
(Kushkina et al., 2013; Wittmann et al., 2014). This
enables a delay in host lysis, but consequently results in
a high increase in the burst size of the phage, providing
phages of this type with a competitive advantage over
others. If this type of phage is integrated within a thera-
peutic cocktail product it could be important to perform
propagation separately; otherwise the phage might domi-
nate the phage population. However, the role of such a
cassette remains uncertain and several additional roles
have been attributed to it, such as being involved in the
host resistance mechanism of the abortive infection
system (Labrie et al., 2010). No virulence or antibiotic
resistance factors were identified in the genome, accord-
ing to the data available at the moment, suggesting that
the P. aeruginosa phage preparation could be safely used
to treat infections related to these bacteria. However, the
majority of putative coding regions of our phages do not
have attributed function in common with the majority of
sequenced phages in GenBank. Consequently, and in
view of the potential of phage therapy as a reliable and
safe therapeutic opportunity, it is important to further
investigate the phage genomes in order to understand the
function of gene products, as they can be involved in
undesirable phage–host interaction or code for novel viru-
lence factors (Lima-Mendez et al., 2011).
Bacterial broth cultures growing with the phage cock-
tails showed an elimination of bacterial cell growth and
suppression of resistant mutants of P. aeruginosa PAO1.
Several studies have demonstrated that the use of a
phage cocktail brings not only advantages regarding the
target host range, but also in terms of preventing or delay-
ing mutations in the population that can result in phage-
resistant clones and therapeutic failure (Tanji et al., 2004;
Gu et al., 2012).
The great majority of microbial infections involve
biofilms (James et al., 2008) and although assessment of
phage lytic activity on bacterial planktonic growth is useful
it is important that biofilm studies are performed when
testing a new antibacterial therapeutic. Previous studies
on P. aeruginosa suggest the potential utility of phages to
reduce and/or eliminate biofilms produced by strains
including PAO1 (Pires et al., 2011), and to prevent biofilm
formation on indwelling medical devices, such as cath-
eters (Fu et al., 2010). The first biofilm model system was
performed under static conditions on a polystyrene
surface for 48 h and phages were added to the biofilms.
Biofilm biomass disruption was quickly observed after
addition of the phage cocktail during the first 6 h of treat-
ment. After 24 h, although the biofilm biomass was still
lower than the PBS-treated biofilm, it was clearly higher
than the previous end-point. By 48 h the biofilm showed a
complete regrowth with a biomass higher than the non-
treated biofilms. The regrowth was not caused by a lack of
phage particles because phages were recovered from the
disrupted biofilms. This has also been observed else-
where (Pires et al., 2011) and it might be a consequence
of a longer interaction of the phage with the bacteria, also
enhanced by a slower metabolic activity of the bacteria in
the biofilm where phage proliferation is slowed down,
resulting in the emergence of phage-resistant clones in
the bacterial population (Bohannan and Lenski, 2000).
Comparing the effect of the phage cocktails on broth
cultures to biofilms, a more positive and rapid effect was
observed in eliminating the bacterial load of broth cultures
than for biofilms, which were disrupted at a lower rate.
This scenario is thought to be due to the metabolic state
of the cells in a biofilm (Chen et al., 2012). This has been
also been shown for antibiotic drugs where bacteria in
biofilms can be much more resilient than those in plank-
tonic culture (Hoyle and Costerton, 1991). A bacterial
culture growing in a chemostat leads to constant concen-
trations of bacterial cells, their products, waste and media
components and, hence, provides a controlled environ-
ment for bacteria to grow at a specific growth rate that will
directly impact cell wall protein expression and secretion
of extracellular polysaccharides (Terry et al., 1991). This
in turn will ultimately determine how mature and protected
the biofilm, which results from such cells, will be
(McEldowney and Fletcher, 1986). The time taken for
biofilm disruption in this system was longer, compared
with that of the static biofilm model, and regrowth was not
observed within the timeframe of the experiment. This
might be related to the structure of the biofilms produced
from a continuous culture and matured under flow condi-
tions, which are likely to resemble more a natural biofilm.
The work presented here shows the characterization of
six isolated phages for P. aeruginosa and assessment
of their activity in different bacterial growth models:
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planktonic, static biofilm and dynamic biofilm. It highlights
the importance of testing phage cocktails on different
biofilm models, as expression of polysaccharides, cell
signalling and ultimately resilience to external stresses is
strongly affected by a myriad of factors and strategies,
where the success of a therapeutic might be strongly
dependent. The studies performed suggest that the use
of phage cocktails, in this case against P. aeruginosa,
could provide practical alternatives to antibiotic treat-
ments for combating biofilm-related infections and in par-
ticular the devastating effects of biofilm-related CF
infections; however, characterization and exploration of
the cocktail biofilm eradication potential need to be further
investigated.
Experimental procedures
Bacteria and growth conditions
Pseudomonas aeruginosa strains (listed in Table 1) used in
this study include PAO1 and clinical isolates from acute and
chronic infections, such as a bacteraemia and CF sputum.
Bacteria from Luria–Bertani (LB) agar plates were grown at
37°C with constant shaking (170 rpm) in LB. LB agar and
LB-soft agar containing 0.65% bacteriological agar were
used for bacteriophage propagation and plaque count
assays. Note that the medium was supplemented with 1 mM
CaCl2 and 1 mM MgSO4 to improve phage adsorption
(Tucker, 1961). Bacterial aliquots were stocked at −80°C in
broth containing 15% (v/v) glycerol.
Bacteriophage isolation
Bacteriophages were isolated from crude sewage (Wessex
Water, Bristol, UK) and flood water (Bath, UK) samples. Bac-
terial enrichments with P. aeruginosa isolates were per-
formed to increase phage numbers as follows: 5 ml of
actively growing P. aeruginosa cells (from overnight liquid
culture in LB) and LB supplemented with 1 mM MgSO4 and
1 mM CaCl2 final concentration. The enrichment was incu-
bated overnight at 37°C. A 10 ml of aliquot was taken from the
overnight culture, and 1 M NaCl and 0.2% chloroform were
added. The culture was then centrifuged (30 min, 3000 × g)
to remove bacteria, and the supernatant was filtered-
sterilized (0.22 μm pore size; Millipore filter). This lysate
(supernatant) was used to check the presence of lytic phages
using the double layer method as described previously
(Adams, 1959). Isolated single plaques were picked into SM
buffer [100 mM NaCl, 8 mM MgSO4, 50 mM Tris-HCl (pH
7.5), 0.01% (w/v) gelatine in MilliQ water (dH2O)], and suc-
cessive rounds of single plaque purification were carried out
until purified plaques were obtained, reflected by a single
plaque morphology. Purified phages were stored in 50% (v/v)
glycerol at −80°C for long-term use. Short-term stock prepa-
rations were maintained at 4°C.
Bacteriophage propagation
Phage lysates were propagated on PAO1 strain. Briefly,
100 μl of phage lysate and 100 μl of host-growing culture
were mixed and left for 5 min at room temperature. Afterward,
3 ml of LB-soft agar was added and poured onto LB agar
plates. The following day, after an overnight incubation at
37°C, plates displaying confluent lysis were selected and
3 ml of SM buffer and 2% (v/v) chloroform were added before
incubation at 37°C for 4 h. High-titre phage solution was
removed from the plates, centrifuged (8000 × g, 10 min) to
remove cell debris, and then filter sterilized (pore size,
0.22 μm) and stored at 4°C.
Sensitivity assay
To determine phage sensitivity of bacterial isolates, spot tests
were performed. Briefly, 3 ml of LB-soft agar was added to
100 μl of host-growing culture and poured onto LB agar.
Plates were left to dry for 20 min at 37°C. The different phage
lysates were standardized to a titre of 109 pfu/ml, and 10 μl of
each lysate was spotted onto the bacterial lawns. This assay
was performed in triplicate. The plates were allowed to dry
before incubation overnight at 37°C. The following day, the
sensitivity profiles of each of the bacterial strains were deter-
mined: if the bacterial lawn was lysed, slightly disrupted, or
not disrupted, the bacterial isolate was labelled sensitive,
intermediate or resistant to the phage infection respectively.
Electron microscopy
Phage particles in water were deposited on carbon-coated
copper grids and negatively stained with 1% uranyl acetate
(pH 4). Visualization was performed using a TEM
(JEM1200EXII; JEOL, Bath, UK) operated at 120 kV. Size
approximations were then performed using image analysis
(ImageJ Software).
Phage DNA extraction, DNA sequencing, analysis
and assembly
Phage genomic DNA was extracted through a direct plaque
sequencing described by Kot and colleagues (2014). DNA
sequencing libraries were prepared using the Nextera XT
DNA kit (Illumina, San Diego, CA, USA) according to the
manufacturer’s protocol. Individually tagged libraries were
sequenced as a part of a flow cell as 2- by 250-base paired-
end reads using the Illumina MiSeq platform (Illumina).
Reads were analysed, trimmed and assembled using 6.5.1
CLC Genomic Workbench as described before (Kot et al.,
2014). Genes were predicted and annotated using the RAST
server (Aziz et al., 2008). Phage genomes were searched for
antimicrobial resistance determinants using the web-tool
RESFINDER (Zankari et al., 2012) that uses the BLAST algo-
rithm (98% ID threshold). The web-tool VIRULENCEFINDER
(Joensen et al., 2014) was used for the search of genes
potential coding for virulence factors (98% ID threshold)
found in Escherichia coli, Enterococcus spp and Staphylo-
coccus aureus.
Planktonic cultures treated with phage mixture
Planktonic cultures were performed in 96-well microtitre
plates, and their optical density was measured. In summary,
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a 1:100 dilution was prepared in the wells of the microplate by
adding 5 μl of an overnight culture to 195 μl of LB. After 2 h of
incubation at 37°C, the single or mixed phages at a desired
MOI were added and the microplates were incubated for a
further 22 h. The incubation was followed on a plate reader
(FLUOstar Omega; BMG LabTech, UK) where the growth
curves were established at an optical density at 600 nm
(OD600). This approach allowed observation of the phage–
bacterium interaction over time and also allows for monitoring
of the appearance of resistant mutants for each phage lysate.
Biofilm formation under static conditions
The biofilm assay for formation of P. aeruginosa biofilms was
based on the previously described methods of Pires and
colleagues (2011) with some modifications where appropriate.
Formation of the biofilms was carried out in 96-well polysty-
rene tissue culture microplates (Nunclon Delta Surface; Nunc,
UK). An overnight culture was diluted to a titre of 108 cfu/ml. In
the microplate wells a 1:100 dilution was achieved by adding
5 μl of the bacterial suspension to 195 μl of half-strength LB
supplemented with 1% D-(+)-glucose (LBg) media, making a
starting inoculum of 106 cfu/ml. A total of 200 μl of broth only
was added to a set of wells as a negative control.All wells were
replicated three times. Afterwards, microplates were incu-
bated at 37°C for 48 h with orbital constant shaking (120 rpm)
for 48 h. Microplates were carefully wrapped with a layer of
moistened blue paper towel roll and plastic to prevent the
media in the microplates from evaporating. At 24 h, 50 μl of
media was carefully removed from all wells and replenished
with 50 μl of fresh 50% LB. Following incubation, media was
poured off and wells were carefully washed twice with PBS to
remove any planktonic cells. Microplates were allowed to dry
for 1 h at 50°C. To determine total biofilm biomass, microplate
wells were stained with 0.1% crystal violet (CV). After staining,
the wells were washed twice with PBS solution and dried.
Biofilm formation was determined by visual comparison of the
stained wells and photographed.
Biofilm treatment with phage mixture and analysis
Once biofilms were established and washed once with PBS,
100 μl of phage mixture in LB was added to a set of wells. Two
MOIs were set up for the phage cocktail. A total of 100 μl of LB
were added to both the positive and negative controls. All the
experiments were performed three times. After static incuba-
tion at 37°C, microplates were washed and stained with crystal
violet to determine biofilm biomass at predetermined time
points. Optical density readings of the crystal violet staining
intensity were performed: 100 μl of 95% (v/v) ethanol was
added to each well and optical density at 600 nm (OD600) was
measured using a plate reader. To determine the cellular
activity of the biofilm an XTT reduction assay was performed
after biofilms had been washed twice with PBS. Following this
1 ml of XTT solution was added to each well and the microtitre
plates were then incubated in the dark for 3 h at 37°C with
constant shaking (120 rpm). Absorbance was then measured
using the FLUOstar plate reader at 490 nm. To determine the
number of viable cells and phages particles within the biofilm,
wells were washed twice with PBS and after 200 μl of PBS
were added to the wells and the bottom and walls of the wells
were scraped with a loop. The contents of each well were
recovered with a pipette after five times pipetting up and down
for complete disruption and detachment of cells to the surface.
Serial dilutions were performed in ferrous ammonium sulfate
(FAS), a virucide (McNerney et al., 1998) that ensures the
inactivation of free phages prior to viable bacterial counts. A
FAS stock solution was prepared immediately before use in
10 ml distilled water and filter sterilized (0.22 μm pore size)
and was used at a working concentration of 10 mM. After
standing at room temperature for 15 min, dilutions were plated
out and bacterial colonies enumerated. For enumeration of
phages present in the biofilm, an aliquot of 100 ml of the
disrupted suspension was used to produce serial dilutions in
PBS and phages were enumerated.
Biofilm formation under flow conditions
A chemostat system was used to generate a continuous
bacterial pure culture of P. aeruginosa PAO1 in order to
provide inoculum to use in the MRD as described by Jass and
collegueas (1995) with some modifications. The culture was
grown in a 500 ml double wall chemostat vessel (Tyler
Research Corporation, Canada) with constant stirring at
300 rpm at controlled temperature (37°C ± 0.2). A 10 ml
sample of an overnight culture with 108 cfu/ml was used to
inoculate 500 ml of sterile fresh LB. Following incubation, the
stirred chemostat was operated as a batch culture for 4 h to
allow the establishment of the culture. After, the medium
volume inside the vessel was kept at 500 ml and perfused with
sterile LB at a dilution rate of 0.1 h−1. The chemostat was run
over 48 h for the culture to achieve the steady state, with a
constant population size of 3.6 × 107 cfu/ml being established.
Astainless steel Robbins Device (Tyler Research Corporation,
Canada) was used to establish a biofilm. The device provides
quantifiable samples of biofilm that can be monitored over
time. It consists of hollow rectangular stainless steel tubes with
12 evenly spaced sampling ports. Each port allowed the
insertion of a sampling stud that contained a stainless steel
disc that lay flush to the inner surface of the lumen being
subjected to the flow media and bacteria. Every stud was
dipped into a sterile solution of mucin (100 μg/ml) to improve
attachment of bacterial cells (McGuckin et al., 2011). The
MRD was fitted into a thermal liquid regulated container (Tyler
Research Corporation) in order to maintain the internal lumen
temperature at 37°C. The culture growing under steady state
was pumped through the MRD over 24 h, via the effluent
tubing (flow rate = 250 μl/min) of the chemostat and biofilms
were allowed to develop. Over this period the culture feed was
replaced by fresh half-strength media supplemented with
0.1% D-(+)-glucose (LBg) for another 24 h. At this time point,
biofilms had been growing for 48 h, and fresh media feeding
was paused in order to inoculate into the system 10 ml of 107
pfu/ml phage in an oil-in-water nano-emulsion suspension
(organic phase: 5% (w/w) soybean oil; surfactant: 15% (w/w)
Brij O10; aqueous phase: SM Buffer) performed through
thermal phase inversion emulsification according to the
method described previously (Esteban et al., 2014) and the
control. Such emulsion was used to promote the lytic activity of
the phage particles, as they provide a more stable environ-
ment for adsorption to the cells to occur (Esteban et al., 2014).
Once the suspension was inside the MRD the inlet and outlet
tubing of the MRD were clamped for a period of 20 min and
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phages were allowed to adsorb to the bacteria in the biofilms.
One hour later the inlet and outlet tubing of the MRD were
clamped again, and four random studs were removed in order
to sample the biofilm communities formed. The removed studs
were replaced with new sterile studs. The stainless steel discs
were unscrewed from the studs and then three were pro-
cessed for viable bacterial and phage counts and the fourth
was prepared for analysis by the confocal laser scanning
microscope (CLSM). Studs were removed from the MRD at
predetermined time intervals: 0, 24 and 48 h.
Viable bacterial and phage counts on MRD disks
Disks were carefully detached using tweezers from the stud
and rinsed twice by dipping the disk in 1 ml in of PBS to
remove planktonic and loosely adherent cells. The disk was
placed in 1 ml PBS contained in 1 ml centrifuge tube and
sonicated for six min (60W) before vortexing for 2 min to
ensure complete detachment of the biofilm from the disk. For
enumeration of viable bacterial cells, serial dilutions were
performed in FAS virucide, and numbers determined by
standard plate assay. For enumeration of phages present in
the biofilm, 100 μl of the disrupted biofilm suspension was
serially diluted and titrations were performed for phage enu-
meration. All the manipulation was performed inside a filtered
lamina flow cabinet to prevent introduction of contamination.
CLSM analysis on MRD disks
Discs were carefully removed and the biofilm surface was
washed twice with PBS. Biofilm cell viability was determined
using LIVE/DEAD® BacLight™ Bacterial Viability Kit staining
following the manufacturer’s instructions. The discs were
immersed in the staining solution and incubated at room
temperature for 15 min in the dark. After staining, the discs
were gently rinsed with PBS and this was repeated six times
more. The biofilm images were acquired in a Zeiss
LSM510META CLSM. Biofilms were observed using the
20× objective (20×/0.5 W). Images were acquired with
1024 × 1024 resolutions in at least three different regions of
the biofilm surface. Manipulation of the images and 3D recon-
structions were performed using LSM Image Browser and
IMARIS 7.4.2 software.
Data analysis
Comparisons between the different time points and the posi-
tive controls were made by performing Student’s t-test, with a
P-value of 0.05 or less was considered statistically significant
for all cases. All tests were performed with a confidence level
of 95%. Spread of data at the 95% CI was estimated using
the WINPEPI freeware statistical analysis program (Abramson,
2011).
Nucleotide sequence accession numbers
The genome sequences of the isolated phages DL52–DL68
have been deposited in the GenBank database under acces-
sion number KR054028-KR054033.
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